Spectranetics

The Spectranetics Corporation, founded in 1980, develops, manufactures, markets, and distributes single-use medical devices for minimally invasive cardiovascular procedures. The company's products are primarily used for treating arterial blockages in the heart and legs, as well as for the removal of pacemaker and defibrillator leads. Approximately 60% of the company’s revenue comes from products related to the excimer laser system—CVX-300. The company’s disposable laser catheters have a diameter of up to 250, and their flexible optical fibers can reach difficult peripheral and coronary areas. The company believes that its excimer laser system is the only laser system approved for minimally invasive cardiovascular procedures in the United States, Europe, Japan, and Canada.